This article is more than 5 years old. Information may no longer be current.
Jerry A. Shields receives first Brady-Shields Endowed Chair in Ocular Oncology
Click Here to Manage Email Alerts
PHILADELPHIA — Wills Eye Hospital presented the Brady-Shields Endowed Chair in Ocular Oncology to inaugural recipient Jerry A. Shields, MD, co-founder and director emeritus of the Ocular Oncology Service at Wills Eye Hospital.
The chair was presented to Shields during a special ceremony at the annual Atlantic Coast Retina Club and Macula Meeting.
“I was asked to leave retina 30 years ago to be in oncology, and I graciously accepted that. Nowhere in the world are there two departments that work so closely together, other than Wills oncology and retina. It’s wonderful. If we see a patient that needs care, we don’t call retina and make an appointment. The patient goes there immediately in that day and gets a consult. ... It’s a nice thing for the patients,” Shields said at the meeting.
Shields’ career spans 50 years in the care and management of patients with ocular tumors. Shields has authored or co-authored more than 1,700 scientific publications and nearly 20 major textbooks. He received the 2014 American Academy of Ophthalmology’s Laureate Award, the organization’s highest honor.
According to Wills Eye, the chair will provide critical research funds necessary to develop new advances and techniques to treat ocular oncology diseases.
“This chair will in perpetuity honor the Brady and Shields name and support research and innovation to advance the cure of ocular tumors,” Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye, said at the presentation.
The chair is named for three pioneering physicians in ophthalmology and oncology: Luther W. Brady Jr., MD, a Drexel University professor and Hylda Cohn/American Cancer Society professor of clinical oncology; Carol L. Shields, MD, director of the Ocular Oncology Service at Wills Eye Hospital and professor of ophthalmology at Thomas Jefferson University; and Jerry Shields.
Colleague and friend Lawrence A. Yannuzzi, MD, founder of Vitreous Retina Macula Consultants of New York, congratulated Shields for the honor and thanked him for teaching him so much during his career.
“I just want to take this moment to thank you. I have learned so much from you, and everybody in this room will join me in agreeing that you have educated us at meetings like this, and we thank you,” Yannuzzi said. – by Robert Linnehan
Reference:
The dedication of the Brady-Shields Endowed Chair in Ocular Oncology. Presented at: Atlantic Coast Retina Club and Macula meeting; Jan. 11-13, 2018; Philadelphia.